FNDC4 and FNDC5 Attenuate SARS‐CoV‐2 S1‐Induced Inflammatory Responses in Human Adipose Tissue
European Journal of Clinical Investigation · 2026-05 · 56 (5)
DOI: 10.1111/eci.70215 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Investigation, online erschienen am 28.04.2026. Verfasst von Gabriela Neira und 11 weiteren Autor:innen. Beteiligte Einrichtung: Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain. Hauptthemen laut MEDLINE: Obesity, Spike Glycoprotein, Coronavirus, Fibronectins, COVID-19. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Departamento de Salud, Gobierno de Navarra, Gobierno de Navarra.
Abstract (Originalsprache)
Background
Adipose tissue is recognised as a SARS‐CoV‐2 reservoir and potential infection site. We herein characterised SARS‐CoV‐2 entry points in visceral (VAT) and subcutaneous (SAT) adipose tissue from people with obesity and determined whether the adipo‐myokines FNDC4 and FNDC5 modulate SARS‐CoV‐2 spike glycoprotein subunit 1 (S1)–induced inflammation in adipocytes and macrophages.
Methods
Plasma concentrations of FNDC4, FNDC5 and angiotensin‐converting enzyme 2 (ACE2) were measured in 183 participants with obesity and normal weight. Expression of SARS‐CoV‐2 host cell entry receptors was analysed in paired VAT and SAT biopsies ( n = 121). The effects of FNDC4 and FNDC5 on S1‐induced inflammatory responses were evaluated in vitro using human visceral adipocytes and THP‐1‐derived macrophages.
Results
Obesity was associated with higher circulating ACE2 and increased expression of SARS‐CoV‐2 entry receptors (ACE2, CD147, DPP4 and neuropilin‐1) in VAT, whereas plasma FNDC4 and FNDC5 levels were reduced. FNDC4, FNDC5 and ACE2 co‐localised with macrophage populations in VAT, and FNDC4 and FNDC5 transcripts positively correlated with genes involved in viral entry and priming. Both adipo‐myokines attenuated S1‐induced M1 macrophage polarisation and HMGB1 secretion and reduced HMGB1 expression in adipocytes.
Conclusion
Reduced FNDC4 and FNDC5 levels in obesity may amplify SARS‐CoV‐2 S1‐induced inflammatory responses in VAT macrophages and adipocytes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Metabolic Research Laboratory, Clínica Universidad de Navarra, Pamplona, Spain.
- CIBER Fisiopatología de la Obesidad y Nutrición (CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain.
- Institute for Nutrition and Health, University of Navarra, Pamplona, Spain.
- Obesity and Adipobiology Group, Instituto de Investigación Sanitaria de Navarra (IdiSNA), Pamplona, Spain.
- Department of Pathology, Anatomy and Physiology, University of Navarra, Pamplona, Spain.
- Department of Surgery, Clínica Universidad de Navarra, Pamplona, Spain.
ORCID-Profile: Gema Frühbeck, Amaia Rodríguez
Förderung
- Instituto de Salud Carlos III
- Departamento de Salud, Gobierno de Navarra
- Gobierno de Navarra
Zitieren
APA
Neira, G., Hernández-Castañeda, J., Catalán, V., Becerril, S., Martín, M., Valentí, V., Moncada, R., Silva, C., Gómez-Ambrosi, J., Escalada, J., Frühbeck, G., & Rodríguez, A. (2026). FNDC4 and FNDC5 Attenuate SARS‐CoV‐2 S1‐Induced Inflammatory Responses in Human Adipose Tissue. European Journal of Clinical Investigation, 56(5). https://doi.org/10.1111/eci.70215
Vancouver
Neira G, Hernández-Castañeda J, Catalán V, Becerril S, Martín M, Valentí V, et al. FNDC4 and FNDC5 Attenuate SARS‐CoV‐2 S1‐Induced Inflammatory Responses in Human Adipose Tissue. European Journal of Clinical Investigation. 2026;56(5). doi:10.1111/eci.70215
BibTeX
@article{Neira2026,
author = {Neira, Gabriela and Hernández-Castañeda, Julia and Catalán, Victoria and Becerril, Sara and Martín, Marina and Valentí, Víctor and Moncada, Rafael and Silva, Camilo and Gómez-Ambrosi, Javier and Escalada, Javier and Frühbeck, Gema and Rodríguez, Amaia},
title = {FNDC4 and FNDC5 Attenuate SARS‐CoV‐2 S1‐Induced Inflammatory Responses in Human Adipose Tissue},
journal = {European Journal of Clinical Investigation},
year = {2026},
volume = {56},
number = {5},
doi = {10.1111/eci.70215}
}
EUVIMED